Qi Su

1.3k total citations
47 papers, 994 citations indexed

About

Qi Su is a scholar working on Molecular Biology, Plant Science and Oncology. According to data from OpenAlex, Qi Su has authored 47 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Plant Science and 9 papers in Oncology. Recurrent topics in Qi Su's work include Garlic and Onion Studies (10 papers), RNA modifications and cancer (6 papers) and Ferroptosis and cancer prognosis (4 papers). Qi Su is often cited by papers focused on Garlic and Onion Studies (10 papers), RNA modifications and cancer (6 papers) and Ferroptosis and cancer prognosis (4 papers). Qi Su collaborates with scholars based in China, Switzerland and Japan. Qi Su's co-authors include Lan Yi, Heling Wang, Hongzhuan Yin, Yan Fu, Di Wu, Qianjin Liao, Yujuan Zhou, Ling Shi, Hui Ling and Jian Su and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Qi Su

47 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Su China 19 474 268 261 215 170 47 994
Zhongping Cheng China 19 600 1.3× 175 0.7× 308 1.2× 116 0.5× 108 0.6× 72 1.2k
Yan‐Jiun Huang Taiwan 17 354 0.7× 226 0.8× 135 0.5× 187 0.9× 89 0.5× 48 901
Zheng Wei China 13 443 0.9× 154 0.6× 149 0.6× 114 0.5× 52 0.3× 42 832
Guangwei Zhu China 16 463 1.0× 235 0.9× 229 0.9× 42 0.2× 106 0.6× 54 812
Weiyan Peng China 21 814 1.7× 202 0.8× 306 1.2× 56 0.3× 176 1.0× 43 1.2k
Biao Geng China 18 738 1.6× 238 0.9× 386 1.5× 113 0.5× 91 0.5× 27 1.2k
Xiaohong Yang China 17 610 1.3× 247 0.9× 183 0.7× 51 0.2× 88 0.5× 56 1.1k
Pamela Leal Chile 17 686 1.4× 186 0.7× 381 1.5× 53 0.2× 108 0.6× 40 1.0k
Kazuhiro Maejima Japan 16 684 1.4× 229 0.9× 244 0.9× 78 0.4× 136 0.8× 39 1.0k
Xuedong Fang China 17 937 2.0× 257 1.0× 674 2.6× 32 0.1× 384 2.3× 34 1.5k

Countries citing papers authored by Qi Su

Since Specialization
Citations

This map shows the geographic impact of Qi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Su more than expected).

Fields of papers citing papers by Qi Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Su. The network helps show where Qi Su may publish in the future.

Co-authorship network of co-authors of Qi Su

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Su. A scholar is included among the top collaborators of Qi Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Su. Qi Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yujia, Ling Xiao, Ming Zhou, et al.. (2025). Which patients with negative PSMA-PET imaging can safely avoid biopsy for prostate cancer? a novel step towards PSMA-based biopsy-free strategy. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2051–2062. 2 indexed citations
2.
Su, Qi, Xing Yi Ling, Zhaoxia Liu, et al.. (2024). MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2. Cellular and Molecular Life Sciences. 81(1). 461–461. 1 indexed citations
3.
Cheng, Wei, et al.. (2024). A crop’s spectral signature is worth a compressive text. Computers and Electronics in Agriculture. 227. 109576–109576. 1 indexed citations
6.
Wang, Rui, et al.. (2021). Knockdown of SFRS9 Inhibits Progression of Colorectal Cancer Through Triggering Ferroptosis Mediated by GPX4 Reduction. Frontiers in Oncology. 11. 683589–683589. 34 indexed citations
7.
Wang, Rui, et al.. (2021). Reconsideration of recurrence and metastasis in colorectal cancer. World Journal of Clinical Cases. 9(24). 6964–6968. 9 indexed citations
8.
Zhang, Yuhong, Qiqi Wang, Wenbin Lu, et al.. (2021). Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology. Journal of Molecular Medicine. 99(12). 1797–1813. 7 indexed citations
9.
Su, Qi, et al.. (2019). A novel cancer stem cell-based classification model for the tumorigenesis and development of colorectal cancer. Translational Cancer Research. 8(7). 2621–2623. 1 indexed citations
10.
Su, Jian, et al.. (2017). Downregulation of LIMK1–ADF/cofilin by DADS inhibits the migration and invasion of colon cancer. Scientific Reports. 7(1). 45624–45624. 44 indexed citations
11.
Ling, Hui, Jie He, Hui Tan, et al.. (2017). Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide. International Journal of Oncology. 50(2). 697–707. 18 indexed citations
12.
Wang, Heling, et al.. (2017). The function of BTG3 in colorectal cancer cells and its possible signaling pathway. Journal of Cancer Research and Clinical Oncology. 144(2). 295–308. 22 indexed citations
13.
Li, Qingye, Jing Qin, Lan Yi, et al.. (2016). Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment. Molecular Medicine Reports. 14(5). 4666–4672. 8 indexed citations
14.
Yi, Lan, Jian Shan, Xin Chen, et al.. (2016). Involvement of calreticulin in cell proliferation, invasion and differentiation in diallyl disulfide-treated HL-60 cells. Oncology Letters. 12(3). 1861–1867. 17 indexed citations
15.
Fu, Yan, et al.. (2016). Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis. Scientific Reports. 6(1). 33789–33789. 52 indexed citations
16.
Su, Bo, Jian Su, Hui He, et al.. (2015). Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches. Oncology Reports. 33(5). 2484–2494. 21 indexed citations
17.
Ling, Hui, et al.. (2014). Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line. Oncology Reports. 32(5). 2274–2282. 20 indexed citations
18.
Yin, Hongzhuan, et al.. (2013). Mutation spectrum in human colorectal cancers and potential functional relevance. BMC Medical Genetics. 14(1). 32–32. 9 indexed citations
19.
Yi, Lan & Qi Su. (2013). Molecular mechanisms for the anti-cancer effects of diallyl disulfide. Food and Chemical Toxicology. 57. 362–370. 132 indexed citations
20.
Zhou, Yujuan, Jian Su, Ling Shi, Qianjin Liao, & Qi Su. (2012). DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Oncology Reports. 29(2). 605–612. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026